Publication Information

{'id': 'https://openalex.org/W2898101012', 'doi': 'https://doi.org/10.1097/jxx.0000000000000115', 'title': 'Overview of the burden of illness and the role of once-weekly glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes', 'display_name': 'Overview of the burden of illness and the role of once-weekly glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes', 'publication_year': 2018, 'publication_date': '2018-10-01', 'ids': {'openalex': 'https://openalex.org/W2898101012', 'doi': 'https://doi.org/10.1097/jxx.0000000000000115', 'mag': '2898101012'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/jxx.0000000000000115', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S125263180', 'display_name': 'Journal of the American Association of Nurse Practitioners', 'issn_l': '2327-6924', 'issn': ['2327-6924', '2327-6886'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5110272769', 'display_name': 'Deborah Hinnen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1288162130', 'display_name': 'University of Colorado Hospital', 'ror': 'https://ror.org/006jjmw19', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1288162130', 'https://openalex.org/I4210087413']}, {'id': 'https://openalex.org/I4210087413', 'display_name': 'University of Colorado Health', 'ror': 'https://ror.org/0107w4315', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210087413']}, {'id': 'https://openalex.org/I921990950', 'display_name': 'University of Colorado Denver', 'ror': 'https://ror.org/02hh7en24', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I921990950']}, {'id': 'https://openalex.org/I4210139229', 'display_name': 'Boehringer Ingelheim (France)', 'ror': 'https://ror.org/03gdpyq31', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I1330995197', 'https://openalex.org/I4210139229']}, {'id': 'https://openalex.org/I4210165704', 'display_name': 'Memorial Hospital', 'ror': 'https://ror.org/05jhpk184', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210087413', 'https://openalex.org/I4210165704']}, {'id': 'https://openalex.org/I3018075036', 'display_name': 'Sanofi (France)', 'ror': 'https://ror.org/02n6c9837', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I3018075036']}], 'countries': ['FR', 'US'], 'is_corresponding': True, 'raw_author_name': 'Deborah Hinnen', 'raw_affiliation_strings': ["Author's contributions: The author discussed the concept, worked on the outline, commented in detail on the first iteration, made critical revisions on later drafts, and has revised and approved the final draft for submission.", 'Competing interests: D. Hinnen has acted as speaker and/or consultant and attended the advisory boards for Novo Nordisk, Eli Lilly & Company/Boehringer Ingelheim, Sanofi, Roche, and Janssen and has worked with various Medical Education companies, including IMNE and France Foundation.', 'Memorial Hospital Diabetes Center, University of Colorado Health, Colorado Springs, Colorado'], 'affiliations': [{'raw_affiliation_string': 'Memorial Hospital Diabetes Center, University of Colorado Health, Colorado Springs, Colorado', 'institution_ids': ['https://openalex.org/I1288162130', 'https://openalex.org/I4210087413', 'https://openalex.org/I921990950', 'https://openalex.org/I4210165704']}, {'raw_affiliation_string': 'Competing interests: D. Hinnen has acted as speaker and/or consultant and attended the advisory boards for Novo Nordisk, Eli Lilly & Company/Boehringer Ingelheim, Sanofi, Roche, and Janssen and has worked with various Medical Education companies, including IMNE and France Foundation.', 'institution_ids': ['https://openalex.org/I4210139229', 'https://openalex.org/I3018075036']}, {'raw_affiliation_string': "Author's contributions: The author discussed the concept, worked on the outline, commented in detail on the first iteration, made critical revisions on later drafts, and has revised and approved the final draft for submission.", 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 6, 'corresponding_author_ids': ['https://openalex.org/A5110272769'], 'corresponding_institution_ids': ['https://openalex.org/I1288162130', 'https://openalex.org/I4210087413', 'https://openalex.org/I921990950', 'https://openalex.org/I4210139229', 'https://openalex.org/I4210165704', 'https://openalex.org/I3018075036'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.199, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.4922, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 62, 'max': 70}, 'biblio': {'volume': '30', 'issue': '1', 'first_page': 'S4', 'last_page': 'S11'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10560', 'display_name': 'Diabetes Management and Research', 'score': 0.9956, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11339', 'display_name': 'Metabolism, Diabetes, and Cancer', 'score': 0.9955, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/dulaglutide', 'display_name': 'Dulaglutide', 'score': 0.893232}, {'id': 'https://openalex.org/keywords/semaglutide', 'display_name': 'Semaglutide', 'score': 0.8830422}, {'id': 'https://openalex.org/keywords/mace', 'display_name': 'Mace', 'score': 0.7258531}, {'id': 'https://openalex.org/keywords/lixisenatide', 'display_name': 'Lixisenatide', 'score': 0.43572214}], 'concepts': [{'id': 'https://openalex.org/C2780533449', 'wikidata': 'https://www.wikidata.org/wiki/Q417762', 'display_name': 'Exenatide', 'level': 4, 'score': 0.94900846}, {'id': 'https://openalex.org/C2779829264', 'wikidata': 'https://www.wikidata.org/wiki/Q21011228', 'display_name': 'Dulaglutide', 'level': 5, 'score': 0.893232}, {'id': 'https://openalex.org/C2909862629', 'wikidata': 'https://www.wikidata.org/wiki/Q27261089', 'display_name': 'Semaglutide', 'level': 5, 'score': 0.8830422}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.81272626}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7803578}, {'id': 'https://openalex.org/C2780739214', 'wikidata': 'https://www.wikidata.org/wiki/Q6723023', 'display_name': 'Mace', 'level': 4, 'score': 0.7258531}, {'id': 'https://openalex.org/C2780473172', 'wikidata': 'https://www.wikidata.org/wiki/Q5572518', 'display_name': 'Glycemic', 'level': 3, 'score': 0.6212432}, {'id': 'https://openalex.org/C185280430', 'wikidata': 'https://www.wikidata.org/wiki/Q14909910', 'display_name': 'Glucagon-like peptide 1 receptor', 'level': 4, 'score': 0.6035358}, {'id': 'https://openalex.org/C2780668416', 'wikidata': 'https://www.wikidata.org/wiki/Q202758', 'display_name': 'Hypoglycemia', 'level': 3, 'score': 0.55484384}, {'id': 'https://openalex.org/C2776442814', 'wikidata': 'https://www.wikidata.org/wiki/Q6659956', 'display_name': 'Lixisenatide', 'level': 5, 'score': 0.43572214}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.42447048}, {'id': 'https://openalex.org/C2781308992', 'wikidata': 'https://www.wikidata.org/wiki/Q2526479', 'display_name': 'Liraglutide', 'level': 4, 'score': 0.40699363}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3758002}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.371274}, {'id': 'https://openalex.org/C2778938600', 'wikidata': 'https://www.wikidata.org/wiki/Q389934', 'display_name': 'Agonist', 'level': 3, 'score': 0.33634788}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.32294646}, {'id': 'https://openalex.org/C2779306644', 'wikidata': 'https://www.wikidata.org/wiki/Q2002370', 'display_name': 'Insulin', 'level': 2, 'score': 0.23803332}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.23005968}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.08155659}, {'id': 'https://openalex.org/C500558357', 'wikidata': 'https://www.wikidata.org/wiki/Q12152', 'display_name': 'Myocardial infarction', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C45393284', 'wikidata': 'https://www.wikidata.org/wiki/Q191012', 'display_name': 'Conventional PCI', 'level': 3, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/jxx.0000000000000115', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S125263180', 'display_name': 'Journal of the American Association of Nurse Practitioners', 'issn_l': '2327-6924', 'issn': ['2327-6924', '2327-6886'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.69, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 52, 'referenced_works': ['https://openalex.org/W1809230663', 'https://openalex.org/W1906693641', 'https://openalex.org/W1976085890', 'https://openalex.org/W1978551604', 'https://openalex.org/W1985941010', 'https://openalex.org/W1991511572', 'https://openalex.org/W2002315361', 'https://openalex.org/W2007221722', 'https://openalex.org/W2034170211', 'https://openalex.org/W2043900831', 'https://openalex.org/W2046667801', 'https://openalex.org/W2054981500', 'https://openalex.org/W2072985084', 'https://openalex.org/W2084948079', 'https://openalex.org/W2086074328', 'https://openalex.org/W2087037051', 'https://openalex.org/W2088834455', 'https://openalex.org/W2090254125', 'https://openalex.org/W2099809616', 'https://openalex.org/W2109093140', 'https://openalex.org/W2112532934', 'https://openalex.org/W2116059552', 'https://openalex.org/W2123946565', 'https://openalex.org/W2126919962', 'https://openalex.org/W2128825255', 'https://openalex.org/W2147602249', 'https://openalex.org/W2152984355', 'https://openalex.org/W2157373537', 'https://openalex.org/W2157891776', 'https://openalex.org/W2160088494', 'https://openalex.org/W2170346806', 'https://openalex.org/W2171651020', 'https://openalex.org/W2340736080', 'https://openalex.org/W2425644022', 'https://openalex.org/W2462710388', 'https://openalex.org/W2519510391', 'https://openalex.org/W2524961794', 'https://openalex.org/W2551448889', 'https://openalex.org/W2572398654', 'https://openalex.org/W2583712097', 'https://openalex.org/W2592428270', 'https://openalex.org/W2593851698', 'https://openalex.org/W2898191354', 'https://openalex.org/W2898293212', 'https://openalex.org/W2898537663', 'https://openalex.org/W2898597022', 'https://openalex.org/W2914394976', 'https://openalex.org/W2917198334', 'https://openalex.org/W4213412326', 'https://openalex.org/W4229629337', 'https://openalex.org/W4246288537', 'https://openalex.org/W952614140'], 'related_works': ['https://openalex.org/W4289779349', 'https://openalex.org/W3045958310', 'https://openalex.org/W2992144798', 'https://openalex.org/W2976394260', 'https://openalex.org/W2963614034', 'https://openalex.org/W2913046323', 'https://openalex.org/W2898101012', 'https://openalex.org/W2592545469', 'https://openalex.org/W2563047690', 'https://openalex.org/W2490399744'], 'abstract_inverted_index': {'The': [0], 'prevalence': [1, 13], 'of': [2, 14, 19, 61, 115, 155], 'type': [3], '2': [4], 'diabetes': [5, 35], '(T2D)': [6], 'is': [7, 23], 'increasing': [8], 'globally,': [9], 'and': [10, 37, 53, 63, 95, 109, 129, 137, 147], 'as': [11], 'the': [12, 17, 106, 113, 153], 'T2D': [15, 30], 'rises,': [16], 'burden': [18, 154], 'its': [20, 39], 'associated': [21, 56, 67], 'comorbidities': [22], 'predicted': [24], 'to': [25, 33, 81, 84], 'increase.': [26], 'Effective': [27], 'treatments': [28], 'for': [29, 112], 'are': [31, 47, 55], 'required': [32], 'improve': [34], 'control': [36, 52], 'reduce': [38], 'negative': [40], 'impact.': [41], 'Glucagon-like': [42], 'peptide-1': [43], 'receptor': [44], 'agonists': [45], '(GLP-RAs)': [46], 'effective': [48], 'in': [49, 70, 127, 139, 144], 'improving': [50], 'glycemic': [51], 'bodyweight,': [54], 'with': [57, 68, 118, 142], 'a': [58], 'low': [59], 'risk': [60], 'hypoglycemia,': [62], 'some': [64], 'have': [65, 78], 'been': [66, 79, 103], 'reductions': [69, 126], 'major': [71], 'adverse': [72], 'cardiovascular': [73], 'events': [74], '(MACE).': [75], 'Once-weekly': [76], 'GLP-1RAs': [77, 90], 'developed': [80], 'overcome': [82], 'barriers': [83], 'treatment': [85, 114], 'adherence.': [86], 'Currently': [87], 'approved': [88, 104], 'once-weekly': [89, 99, 120], 'include': [91], 'exenatide': [92], 'extended-release,': [93], 'albiglutide,': [94], 'dulaglutide.': [96], 'Semaglutide,': [97], 'another': [98], 'GLP-1RA,': [100], 'has': [101, 123], 'recently': [102], 'by': [105], 'US': [107], 'Food': [108], 'Drug': [110], 'Administration': [111], 'T2D.': [116, 156], 'Compared': [117], 'other': [119], 'GLP-1RAs,': [121], 'semaglutide': [122], 'shown': [124], 'greater': [125, 135], 'HbA1c': [128], 'weight': [130], 'over': [131], 'once-daily': [132], 'GLP-1RAs.': [133], 'This': [134], 'efficacy': [136], 'improvement': [138], 'MACE,': [140], 'combined': [141], 'improvements': [143], 'delivery': [145], 'devices': [146], 'dispensing': [148], 'procedures,': [149], 'could': [150], 'help': [151], 'address': [152]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2898101012', 'counts_by_year': [{'year': 2018, 'cited_by_count': 1}], 'updated_date': '2024-12-17T15:58:24.369831', 'created_date': '2018-11-02'}